Safety, Tolerability, and Pharmacokinetics of HL-003 in Healthy Subjects

Clinical trial NCT06867393 · RECRUITING

Trial details

NCT number: NCT06867393
Sponsor: Shanghai Kechow Pharma, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2025-02-28
Primary completion: 2025-08-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.